LNTH

#1280
Lantheus Holdings, Inc
83.9400 USD
+1.45%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
83.9400
83.9400
Faixa anual
50.1550
84.3800
Mudança diária
+1.45%
Mudança mensal
+6.58%
Mudança em 6 meses
+49.73%
Mudança anual
+49.73%
Fechamento anterior
82.7400
Abrir
83.9400
Bid
Ask
Mínimo
83.9400
High
83.9400
Volume
90
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 5.423 B
  • Employee 1 193
  • Founded N/A
  • CEO N/A
  • Website www.lantheus.com
  • Headquarter Delaware, United States
  • FIGI BBG006Q52RD0
  • Industry Fabricantes de medicamentos - especializados e genéricos
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
19.52
Índice preço/fluxo de caixa
2.95

Lantheus Holdings Inc

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

Notícias